Teva Outbids Valeant in $6.8 Billion Deal for Cephalon
Kirkland represented Teva in its deal to acquire Cephalon.
To read the full text of this article, please click here.
Kirkland represented Teva in its deal to acquire Cephalon.
To read the full text of this article, please click here.
